Eisai has announced new 36-month (3-year) efficacy and safety results from its Phase 3 Clarity AD...
NEWS
BioNTech commits £1 billion to UK research with £129 million...
BioNTech has announced a major expansion of its UK footprint, pledging to invest up to £1 billion...
UK biotech investment remains resilient in H1 2025, says BIA...
The UK’s biotech sector has demonstrated resilience in the first half of 2025, according to the...
Siemens accelerates Verified Environmental Transparency with EPD...
Siemens has secured official approval from EPD-Global — the Norwegian programme operator for...

